盡職調查、授權、和意見書
About
重要的商業決策，例如投資新產品或新公司、推出新品牌、收購智財資產、或建立合夥關係，都需要做嚴謹的調查和分析。智財權盡職調查在是否要繼續運作某一項交易及其最終的評估與架構，皆扮演重要角色。在這些關鍵項目上，技術專業和實務經驗是沒有替代品的。我們理解調查必須快速有效地進行，我們擁有經驗豐富的團隊，隨時準備就各種技術提供協助，及時且以符合成本效益的方式進行盡職調查和出具意見書，靈活地因應任何特殊狀況。我們協助評估市場上具競爭力的全景，並提供有力的意見書確認未侵權，或協助擬訂得以清除路障以達成商業目標的論據。我們也會一併考量智財周邊有潛在影響的領域，例如貿易和出口管制或隱私議題。透過數十年與成熟和新興產業客戶的密切合作，我們知道該詢問什麼以及該聚焦的項目，以滿足客戶的需求。
Practice Areas
Due Diligence
In fast-moving, high-pressure mergers, acquisitions, partnering, and investment transactions, obtaining an accurate and comprehensive intellectual property evaluation is critical.
出口管制
貿易及出口規定牽涉的範圍十分廣泛，影響所及包括出口原料、軟體與技術的美國公司或組織，以及自家產品可能使用到上揭美國出口產品的非美國公司。
Freedom to Operate Opinions
A Freedom to Operate (FTO) opinion helps limit the risk of future litigation and avoid unnecessary expense related to a new product or acquisition.
Licensing, Pooling, and Other Transactions
Leveraging patents, trade secrets, or portions of an IP portfolio can often generate revenue streams, open new markets, or shut down competitors.
Opinions and Counseling
Opinions of IP counsel ranging from freedom to operate to licensing potential are crucial for innovative companies assessing the risk and reward for investing in product commercialization.
Patent Mining and Mapping
Understanding your IP assets in a larger context can help reveal market position, identify potential threats or roadblocks to maneuver around, and expose white space and opportunities for moving forward with confidence.
Privacy
From data gathering to data storage, from privacy by design to governance and legal compliance, all industries and sectors are faced with complex and often unsettled issues related to privacy.
標準必要專利 (SEPs)
標準必要專利 (SEP) 是一種被納入某特定技術標準的發明。處理標準必要專利的訴訟和授權談判需要特定類型的經驗。
Experience
Advised a consumer-focused private investment firm on healthcare regulatory aspects of its definitive agreement to acquire a majority stake in a skin barrier and skin health brand.
Advised a global investment firm on patent and life sciences regulatory aspects in respect of medicines for rare diseases and specialty care products.
Advised a global life sciences company on (non-)infringement issues relating to a chemistry-related patent covering an anti-cancer drug for treating leukemias.
Advised a pulmonary drug delivery company on (non-)infringement issues relating to inhalers.
Advised a leading private equity firm on patent litigation and life sciences regulatory aspects on its acquisition of a leading European pharmaceutical company.
[2020] UKSC 27, Appeal number: UKSC 2018/0131, Supreme Court of the United Kingdom
